FORMULATION OF NANOPARTICLES OF EPROSARTAN MESYLATE FOR THE BETTER DRUG DELIVERY BY IMPROVING SOLUBILITY

Upasana Yadav; Nuzhat Husain; Qamar Rehman

doi:10.22159/ajpcr.2018.v11i10.26915

Authors

Upasana Yadav Department of Biotechnology, School of Applied Sciences, Amity University, Lucknow, Uttar Pradesh, India.
Nuzhat Husain Department of Pathology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Qamar Rehman Department of Biotechnology, Amity University, Lucknow, Uttar Pradesh, India.

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i10.26915

Keywords:

Eprosartan, Nanoparticle, Carboxymethyl chitosan, Reverse micellar method

Abstract

Objective: In the present study, we have made an attempt to the developed formulation of nanoparticles (NPs) of eprosartan mesylate (EM) incorporated in carboxymethyl chitosan using reverse micelle technique for the better drug delivery by improving solubility.

Methods: The NPs size and morphology were investigated by high-resolution transmission electron microscopy and field emission scanning electron microscopy, respectively. The physical and chemical aggregation state of eprosartan was analyzed using ultraviolet spectroscopy, and Fourier transforms infrared spectroscopy.

Results: To increase the solubility of eprosartan by reverse micelle technique of the drug through polymeric NPs is an alternative efficient, option for increasing the solubility. Eprosartan nanosuspension was successfully formulated for dissolution and bioavailability enhancement of the drug. The percentage drug release pattern of both formulations was compared against that of pure drug. It shows that in 10 min 39% and 17% of drug was released from the NPs made by RM method and microemulsion method, respectively, as compared to that of 1.3% of the pure drug. In 50 min almost more than half 51% of the drug was released from NPs by microemulsion method whereas only 2.5% of the drug was released from NPs containing the pure drug. In 120 min 67% of the drug was released from NPs by microemulsion method whereas only 5.8% of drug release was shown by NPs with the pure drug. We are paying attention on evaluating the influence of particle size and crystalline state on the in vitro performance of eprosartan.

Conclusion: In summary, we have developed a new approach toward the delivery of poorly water-soluble drug eprosartan by reverse micellar method. The particle size of NPs obtained by the reverse micellar method was significantly reduced as compared to the other method.

Downloads

Download data is not yet available.

Author Biography

Upasana Yadav, Department of Biotechnology, School of Applied Sciences, Amity University, Lucknow, Uttar Pradesh, India.

Department of Amity school of applied sciences, associate professor

References

Anantha RG, Harish MN, Arthob NY, Keshavayya J, Venugopala RK. High performance liquid chromatographic analysis or determination of eprosartan mesylate in bulk drug. J Chem Pharma Res 2011;3:945-49.

Chandana OS, Sathis DK, Ravichandra B. Method development and validation of eprosartan mesylate and its imputies using reverse phase high performance liquid chromatography. Int J Curr Pharm Res 2016;8:49-53.

Rao ME, Suryakanta S, Shakti PM. Formulation design, optimization and characterization of eprosartan mesylate nanoparticles. Nanosci Nanotechnol Asia 2018;8:130-43.

Rewar S, Bansal BK, Singh CJ, Sharma AK. Approch for quantitative estmation of eprosartan mesylate by UV spectrophotometer. Int J Res Dev Pharm Lif 2014;3:1300-03.

Gassmann P, List M, Schweitzer A, Sucker H. Hydrosols-alternatives for the parenteral application of poorly water soluble drugs. Eur J Pharm Biopharm 1994;40:64-72.

MÃ¼ller RH, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv Drug Deliv Rev 2001;47:3-19.

Dolenc A, Kristl J, Baumgartner S, Planinsek O. Advantages of celecoxib nanosuspension formulation and transformation into tablets. Int J Pharm 2009;376:204-12.

Jinno J, Kamada N, Miyake M, Yamada K, Mukai T, Odomi M, et al. Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J Control Release 2006;111:56-64.

MÃ¼ller RH, Peters K. Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique. Int J Pharm 1998;160:229-37.

Dong Y, Ng WK, Shen S, Kim S, Tan RB. Preparation and characterization of spironolactone nanoparticles by antisolvent precipitation. Int J Pharm 2009;375:84-8.

Kesisoglou F, Panmai S, Wu Y. Nanosizingâ€“oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev 2007;59:631-44.

Krishna SA, Amareshwar P. Preparation of bovine serum albumin loaded chitosan nanoparticle using reverse micelle method. Res J Pharm Biol Chem Sci 2011;2:837-46.

Abdol QM, Mohamed AO, Gamal M, Maghraby EL. Intestinal absorption of eprosartan mesylate from self emulsifying system and cyclodextrin complex. Int J Pharm Pharm Sci 2017;9:302-7.

Jassem NA, Rajab NA. Formulation and in-vitro evaluation of azilsartan medoxomil nanosuspension. Int J Pharm Pharm Sci 2017;9:110-9.

Krishna SA, Amareshwar P, Chakravarty P. Different techniques used for the preparation of nanoparticles using natural polymers and their application. Int J Pharm Sci 2011;3:45-50.

Graham B, Breezer AE. The relationship between particle size and solubility. Int J Pharm 1992;3:82.

Yadav U, Chowdhuri AR, Sahu SK, Husain N, Rehman Q. Formulation of nanoparticles of telmisartan incorporated in carboxymethyl chitosan for the better drug delivery and enhanced bioavailability Asian J Pharm Clin Res 2017;10:236-41.

Chen XG, Park HJ. Chemical characteristics of O-carboxymethyl chitosans related to the perpartion condition. Carbohydrate 2003;53:355-9.